{
    "2018-07-10": [
        [
            {
                "time": "",
                "original_text": "药明康德、宁德时代之后，又一巨头迈瑞医疗冲刺A股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "宁德时代",
                        "迈瑞医疗",
                        "A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[天眼] 独角兽长飞光纤断向A股 H股3年涨6倍",
                "features": {
                    "keywords": [
                        "长飞光纤",
                        "A股",
                        "H股",
                        "涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "通信",
                        "光纤"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[看好评级] 医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点关注稳健成长和“流量入口”型公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报业绩",
                        "医疗需求",
                        "稳健成长",
                        "流量入口"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级] 医药生物行业周报：市场或迎来中级反弹 防御为先医药为上",
                "features": {
                    "keywords": [
                        "医药生物",
                        "市场反弹",
                        "防御",
                        "医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "新共响获千万级天使轮投资，要做制造业的“药明康德”",
                "features": {
                    "keywords": [
                        "新共响",
                        "天使轮",
                        "制造业",
                        "药明康德"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制造业",
                        "医药服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“独角兽”药明康德欲开启“A+H”时代",
                "features": {
                    "keywords": [
                        "独角兽",
                        "药明康德",
                        "A+H",
                        "上市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}